Midjourney Unveils CGI Concept Video for Fictional Ultrasound Scanner, Showcasing Future Medical Tech Vision 

The pivot caught the entire AI industry off guard. Midjourney announced a new division called Midjourney Medical on June 17, 2026, at an event in San Francisco, unveiling its first-ever hardware product. CEO David Holz revealed what he called a “full-body ultrasound machine,” named the Midjourney Scanner, claiming “no such device has ever been built until now.” The device uses approximately 500,000 individual transducers and produces a complete body scan in roughly 60 seconds, without radiation. For a company best known for AI-generated images, this marks a complete strategic departure.

Midjourney is trying to reinvent not just images, but healthcare itself.🩻🩺

Midjourney Medical is a new project to build a scanner that feels as powerful as an MRI yet as casual as a spa visit, using ultrasonic waves in a warm pool of water to create high resolution, full body… pic.twitter.com/e1BunKG78E

— Kracked Devs (@KrackedDevs) June 18, 2026

The Technical Specs Behind the Scanner

The Midjourney Scanner uses 8,960 individual transducers arranged in a ring configuration around the patient’s body. The processing demands behind that hardware are staggering.

• The system processes 17 gigabytes of data per second during a single scan session.
• Each cross-sectional slice requires 40GB of raw data just to reconstruct one image.
• The scanner reconstructs a 3D body map down to a fraction of a millimeter, comparable to MRI resolution at nearly 100x the speed.
• Midjourney claims fewer than 12 of these machines could outperform every MRI machine on Earth combined. 

A Licensing Deal Built in Secret Since November

The Butterfly Network Connection

Midjourney signed a co-development and licensing agreement with handheld ultrasound device maker Butterfly Network in November 2025, taking exclusive rights to its ultrasound-on-chip technology. The deal was structured with real financial commitment behind it.

The agreement involved a $15 million upfront payment, $10 million in annual licensing fees over a five-year term, and potential milestone payments up to $9 million. Notably, none of the core scanning technology relies on generative AI, the field that built Midjourney’s reputation.

The Spa Model Not a Hospital Rollout

The Ultrasonic CT will debut in a “Midjourney Spa” planned for launch in San Francisco at the end of 2027. The flagship location will house 10 scanners alongside hot tubs, saunas, and cold plunges.

Midjourney’s stated long-term ambition is a global fleet exceeding 50,000 scanners, delivering roughly 1 billion scans per month by 2031. Regulatory strategy stays cautious at launch; the company says it will initially offer only “body composition maps” rather than diagnostic claims, avoiding immediate FDA clearance requirements. 

Part of a Bigger Industry Pattern

Midjourney’s hardware leap is not happening in isolation. OpenAI confirmed in May 2026 that its internal robotics team is now co-designing physical hardware, with a stated goal of providing every person a general-purpose personal robot. OpenAI separately acquired io Products and is reportedly developing an audio wearable called Sweetpea, targeting 40 to 50 million units in its first year.

Midjourney currently runs eight active projects: four hardware and four software, with plans to ship at least two hardware efforts in the near term. Peer AI and imaging companies including Butterfly Network (NYSE: BFLY) and diagnostic players such as Prenuvo and Ezra operate in the adjacent whole-body imaging space Midjourney is now entering.

Final Thoughts

Holz described his longer-term vision plainly: “Over 10 years, these things are not just imaging devices: They’re probably therapeutic as well.” The underlying Butterfly-licensed technology is concrete, but the promises around scale and pricing remain unproven for now.

Midjourney’s path from generative pixels to diagnostic hardware is unprecedented in the AI industry, and the company’s next test will be turning a single San Francisco spa concept into a regulatory-cleared, scalable medical product.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.